Manual support during robotic-assisted percutaneous coronary intervention
Our findings reveal that nearly one out five of patients undergoing R-PCI required manual support, which was linked to longer procedure durations. Predictors of manual support reflected characteristics of more complex coronary lesions. These results highlight the limitations of current R-PCI platforms and underscore the need for technical advancements to address different clinical scenarios.
Authors
- Helge Möllmann (ORCID: https://orcid.org/0000-0002-6047-0990)
- Alina Goßling (ORCID: https://orcid.org/0000-0002-5211-5593)
- Caroline Kellner (ORCID: https://orcid.org/0009-0000-9693-4622)
- Holger Nef (ORCID: https://orcid.org/0000-0002-2823-3928)
- Constantin von zur Mühlen (ORCID: https://orcid.org/0000-0003-2767-8009)
- Moritz Seiffert (ORCID: https://orcid.org/0000-0002-3940-9079)
- Jonathan Rilinger (ORCID: https://orcid.org/0000-0001-9333-3629)
- Felix Hofmann (ORCID: https://orcid.org/0000-0001-6111-339X)
- Fabian J. Brunner (ORCID: https://orcid.org/0000-0003-0335-8625)
- Benjamin Bay
Institutions
- Universität Hamburg (DE)
- University of Freiburg (DE)
- Universitätsklinikum Gießen und Marburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- German Centre for Cardiovascular Research (DE)
- Universitäts-Herzzentrum Freiburg-Bad Krozingen (DE)
- BG University Hospital Bergmannsheil Bochum (DE)
- St.-Johannes-Hospital Dortmund (DE)
- Segeberger Kliniken (DE)
- Ruhr University Bochum (DE)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1007/s00392-025-02596-6
- Citations
- 2
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- Amgen
- Pfizer
- AstraZeneca
- Sanofi
- Abiomed
- Deutsche Herzstiftung
- Daiichi Sankyo Europe